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Introduction
!
Eosinophilic esophagitis (EoE) is a chronic, in-
flammatory disorder of the esophagus, rapidly in-
creasing in incidence, and characterized clinically
by symptoms related to esophageal dysfunction
and histologically by an eosinophil-predominant
inflammation [1–3]. In itself, this definition un-
derscores the importance of the histopathological
assessment of the esophageal tissue.
Systematic evaluation of scarce surgical resection
specimens as well as findings from endoscopic ul-
trasound studies have convincingly shown that,
in EoE, the inflammatory processes are not re-
stricted to the squamous epithelium of the esoph-
agus but also take place in the deeper esophageal
wall layers, in particular the lamina propria of the
mucosal layer, the submucosal layer, and even the
muscularis and adventitia [4–8]. It is well estab-
lished that uncontrolled inflammation in EoE can
lead to subepithelial fibrosis characterized by ex-
cess deposition of extracellular matrix proteins
[9,10]. This so-called esophageal remodeling
leads to stricture formation, which increases the
risk of food bolus impactions [11,12]. Subepithe-
lial fibrosis might contribute to EoE symptoms
despite apparent mucosal healing. As such, pro-
cesses taking place in deeper layers of the esoph-
ageal wall most likely contribute to symptomgen-
eration in EoE [13].
In EoE, it would be advantageous to get biopsies
that encompass subepithelial tissue as well as epi-
thelium. The reasons for this are twofold: (i) it
would be of interest to physicians and scientists
alike to be able to examine disease-specific altera-
tions occurring more deeply in the esophageal
wall and to improve our understanding of the pa-
thophysiology of EoE; and (ii) it would help pa-
thology technicians to properly orient biopsy spe-
cimens (epithelial side up), which in turn would
make it easier for the pathologist to evaluate the* These authors contributed equally.
Background and aims: Eosinophilic esophagitis
(EoE) is a mixed inflammatory and fibrostenotic
disease. Unlike superficial inflammatory changes,
subepithelial fibrosis is not routinely sampled in
esophageal biopsies. This study aimed to evaluate
the efficacy and safety of deep esophageal sam-
pling with four different types of biopsy forceps.
Patients and methods: In this cross-sectional
study, esophageal biopsies were taken in 30 adult
patients by one expert endoscopist. Biopsies sam-
pled from distal esophagus using a static jaw for-
ceps (Olympus, FB-11K-1) were compared with
proximal biopsies sampled with static jaw (Olym-
pus, FB-45Q-1), alligator jaw (Olympus, FB-210K),
and large-capacity forceps (Boston Scientific, Ra-
dial Jaw 4). One pathologist calculated the surface
area of epithelial and subepithelial layers in he-
matoxylin and eosin (H&E)-stained biopsies.
Results: Subepithelial tissue was acquired in 97%
(static jaw FB-11K-1), 93% (static jaw FB-45Q-1),
80% (alligator jaw), and 55% (large-capacity) of
samples. Median (interquartile [IQR]) ratios of
surface area of epithelial to subepithelial tissue
were: static jaw FB-45Q-1, 1.07 (0.65–4.465);
static jaw FB-11K-1, 1.184 (0.608–2.545); alliga-
tor jaw, 2.353 (1.312–4.465); and large-capacity,
2.71 (1.611–4.858). The static jaw models ob-
tained a larger surface area of subepithelial tissue
compared with the alligator jaw (P<0.001 and P=
0.037, for FB-11K-1 and FB-45Q-1, respectively)
and the large-capacity forceps (P<0.001, for both
static jaw models). No esophageal perforations
occurred.
Conclusions: The static jaw forceps models al-
lowed sampling of subepithelial tissue in >90% of
biopsies and appear to be superior to alligator or
large-capacity forceps in sampling larger
amounts of subepithelial tissue.
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distinct EoE-associated features, such as basal cell hyperplasia or
papillary elongation [14].
Although subepithelial esophageal tissue is not routinely sam-
pled, several models of biopsy forceps currently on the market
can be used to potentially obtain this tissue [15]. However, there
are no studies so far that have systematically assessed the success
rates for sampling subepithelial tissue achieved by endoscopists
using different biopsy forceps models [16]. Furthermore, it is un-
known whether sampling of biopsies containing subepithelial
tissue is associated with complications, such as bleeding necessi-
tating an endoscopic or surgical intervention or esophageal per-
foration.
Given the lack of studies that systematically examine the use of
different biopsy forceps in patients with EoE, we aimed to evalu-
ate the rates with which four different biopsy forceps models can
be used to successfully obtain biopsy specimens containing sube-
pithelial tissue, and the amount of tissue that can be sampled
using these forceps. In addition, we also examined whether in-
clusion of subepithelial tissue is associated with obtaining sec-
tions with proper basoapical orientation. Lastly, we examined
whether the deeper biopsy sampling is associatedwith complica-
tions, such as bleeding or esophageal perforation.
Patients and methods
!
Patients
In this cross-sectional study, adult EoE patients were recruited
(by A.S.) at the Swiss EoE Clinic, Olten, Switzerland. For diagnosis
of EoE, patients fulfilled the following published diagnostic crite-
ria: (i) symptoms of esophageal dysfunction; (ii) peak eosinophil
count of ≥15/high-power field (hpf; magnification ×400) follow-
ing an 8-week treatment with proton-pump inhibitors (PPIs)
(single standard or double dose); and (iii) exclusion of other dis-
orders that might be associated with esophageal eosinophilia
[17]. Patients underwent esophagogastroduodenoscopy (EGD)
because they were either symptomatic or else scheduled for a
regular follow-up visit. Patients with PPI-responsive esophageal
eosinophilia (PPI-REE) were excluded [18].
Patients were recruited from June 2015 to October 2015. Adult
patients (18–80 years) who provided written informed consent
were included in the study. Patients were excluded if they were
pregnant, or receiving anticoagulation treatment that would in-
crease the risk for hemorrhage during esophageal biopsy sam-
pling. The study was approved by the local ethics committee
(EKNZ 2015/388).
Endoscopy and biopsies
One EoE expert endoscopist (A.S.) performed the EGDs with
biopsy sampling according to a standardized protocol. Four distal
and four proximal biopsies were taken from each EoE patient. For
the purposes of the study, the distal esophagus was defined as
the section spanning the lower half of the esophagus, while the
proximal esophagus was defined as the section spanning the up-
per half of the esophagus. The closed biopsy forceps were passed
through the working channel of the endoscope, positioned tan-
gentially to the esophageal wall and then opened. Using suction,
themucosawas pulled towards the tip of the endoscope and then
grasped with the biopsy forceps.
The following biopsy forceps models were evaluated: static jaw,
FB-11K-1 (Olympus Europa, Hamburg, Germany); static jaw, FB-
45Q-1 (Olympus Europa); alligator jaw, FB-210K (Olympus Euro-
pa), and large-capacity, Radial Jaw 4 (Boston-Scientific, Solo-
thurn, Switzerland,). The characteristics of the different forceps
models are presented in●" Fig.1.
Our group recently evaluated the distribution of subepithelial fi-
brosis in 149 adult EoE patients [19]. No difference was found
when fibrosis frequency and severity in the proximal was com-
pared with that in the distal esophagus (P=0.183) [19]. Based on
this observation, four biopsy samples were taken in the distal
esophagus from all 30 patients, using the static jaw FB-11K-1 for-
ceps. In addition four biopsies were taken in the proximal esoph-
agus in each patient, using one of the other three forceps models.
For these proximal esophageal biopsies, the patients were split
into three equal groups (10 patients each), and the static jaw FB-
45Q-1, alligator jaw, and large-capacity forceps were used to take
biopsies from the proximal esophagus in the first, second, and
third groups, respectively.
Histopathological examination
All samples were sent to one EoE expert pathologist (C.B.) for
processing and evaluation (at the Viollier Institute of Pathology,
Allschwil, Switzerland). Sections of thickness 4µm were cut
from paraffin blocks and then stained with hematoxylin and eo-
sin (H&E) for examination by light microscopy. Slides were eval-
uated using a Zeiss Axio Imager.A2 microscope (Carl Zeiss, Feld-
Forceps model
Producer and
type
Olympus 
FB-11K-1
Olympus 
FB-45Q-1
Olympus 
FB-210K
Boston Scientifi c
Radial Jaw 4
Minimum required
working channel,
mm
2.8 2.2 2.8 2.8
Features Side-opening,
round cups,
multi-use
Side-opening,
round cups,
multi-use
Swinging
alligator jaws,
single-use
Radial 
alligator jaws, 
large-capacity, 
single-use
Fig.1 Characteristics of four models of biopsy
forceps used in evaluation of efficacy and safety of
deep esophageal sampling.
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bach, Switzerland) with a high power field (hpf) area of 0.260
mm2 (a high power field represents× 400 magnification).
At least 15 interval sections of every esophageal biopsy specimen
were surveyed under magnification× 100 (low power field), and
the eosinophils in the most densely infiltrated area were counted
under high power examination. The following features were re-
corded: sample orientation (sectioned perpendicularly to the lu-
minal surface, yes vs. no), percentage of the hpf covered by the
tissue, peak number of eosinophils/hpf, distribution of eosino-
phils in a hpf, presence of eosinophilic microabscesses (aggrega-
tion of>10 eosinophils), basal layer enlargement, and lamina
propria fibrosis. Lamina propria fibrosis was evaluated categori-
cally (absent, mild–moderate, severe) following the histopathol-
ogy protocol of the eosinophilic esophagitis activity index (EEsAI)
study [19].
The surface areas of the epithelial and subepithelial layers were
calculated by measuring the circumference of these layers
(●" Fig.2). In addition, the ratio of the surface area of the sampled
epithelial tissue to that of the subepithelial tissue was calculated
for each type of biopsy forceps used.
The assessment of the severity of EoE-associated endoscopic
findings, such as white exudates, rings, edema, furrows, and
stricture(s), was carried out in accordance with the EoE Endo-
scopic Reference Score classification and grading system [20].
Statistical analysis
Data were entered into an Excel spreadsheet (Microsoft Excel
2010; Microsoft Corporation, Redmond, Washington, USA). The
statistical analyses were performed using Stata (version 13.1,
College Station, Texas, USA). Q–Q plots were used to analyze
data distribution. Most data were normally distributed, except
for the values of the ratio of the surface area of epithelial tissue
to the surface area of subepithelial tissue, which followed a non-
parametric distribution. Results of numerical data are presented
either as mean (standard deviation [SD]), or as 95% confidence
intervals (95%CI) for normally distributed data, or as median (in-
terquartile range [IQR]), for nonparametric data.
To compare two groups with regard to a continuous variable, we
used the t test if the variable was normally distributed in both
groups and the Wilcoxon rank sum test if the variable had a
skewed distribution.
Our study was considered to be an exploratory analysis. How-
ever, because of multiple testing and the limited sample size, P
values<0.01 were considered to be statistically significant.
Results
!
Clinical, endoscopic, and histologic characteristics
of EoE patients
A total of 30 adult EoE patients from the Swiss EoE Clinic were in-
cluded (mean [SD] age 45.2 [14.3] years at inclusion; 66.7% men).
The baseline characteristics of these patients are shown in
●" Table1. At the time of undergoing EGD, 13 patients (43.3%)
were asymptomatic, while 17 patients (56.7%) were suffering
Fig.2 Biopsy sampling in eosinophilic esophagitis (EoE). The surface area
of the epithelial and subepithelial layers was calculated using software and
based on measuring the circumference of each individual layer. The section
shows a correct basoapical orientation that allows the evaluation of the
entire depth of the biopsy. (Biopsy sample acquired with the Olympus FB-
11K-1 forceps.)
Table 1 Clinical, endoscopic and histologic characteristics of patients
(n = 30) with eosinophilic esophagitis (EoE) and enrolled in the study.
Age at EoE diagnosis, mean (SD), years 38.6 (17.7)
Age at inclusion, mean (SD), years 45.2 (14.3)
Male gender, n (%) 20 (66.7)
Family history of EoE, n (%)  2 (6.7)
Therapies (ever), n (%)
Oral topical steroids (budesonide or fluticasone) 28 (93.3)
Elimination diet  1 (3.3)
Esophageal dilation  6 (20)
Therapies at current endoscopy, n (%)
Oral topical steroids 23 (76.7)
Elimination diet  0
Esophageal dilation  2 (6.7)
No therapy  5 (16.7)
EoE symptoms at inclusion (patients may have
reported more than one symptom), n (%)
Asymptomatic 13 (43.3)
Dysphagia 17 (56.7)
Food impaction necessitating endoscopic
removal
 0 (0.0)
Thoracic pain, not associated with swallowing  2 (6.7)
Heartburn  1 (3.3)
Swallowing-associated thoracic pain  2 (6.7)
Weight loss  1 (3.3)
Atopic disease, n (%) 25 (83.3)
Allergic rhinoconjunctivitis 12 (40.0)
Asthma  8 (26.7)
Allergic rhinoconjunctivitis and asthma 10 (33.3)
Oral allergy syndrome  6 (20.0)
Urticaria  0 (0.0)
Known food allergies 14 (46.7)
Endoscopic features (patients may have had
more than one endoscopic feature), n (%)
White exudates  9 (30.0)
Longitudinal furrows  8 (26.7)
Edema 18 (60.0)
Corrugated rings 19 (63.3)
Stricture  9 (30.0)
Histologic features (entire esophagus)
Peak eosinophil count per hpf, median (IQR),
(range)
20 (4–35), (0–148)
Eosinophilic microabscesses, n (%) 11 (36.7)
Subepithelial fibrosis, n (%) 25 (83.3)
hpf, high power field; IQR, interquartile range.
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from dysphagia. The majority of patients (83.3%) suffered from
concomitant allergies.
The endoscopic and histologic characteristics of the EoE patients
at the time of endoscopy are shown in●" Table1. Rings were the
most prevalent feature (19/30, 63.3%), followed by edema (18/30,
60%), white exudates (9/30, 30%), strictures (9/30, 30%), and
furrows (8/30, 26.7%). The median peak eosinophil count was
20/hpf. Eosinophilic microabscesses were found in 11 patients
(36.7%), while subepithelial fibrosis was present in 25 patients
(83.3%).
Acquisition of subepithelial tissue by the four models
of biopsy forceps
The success rate for acquisition of subepithelial tissue by the four
different biopsy forceps models is shown in●" Fig.3.
Subepithelial tissuewas acquired inmore than 90% of all biopsies
when static jaw type forceps were used: with the static jaw FB-
11K-1, the success rate was 116/120 (97%, 95%CI 94.7%–100.3%;
with the static jaw FB-45Q-1 it was 37/40 (93%, 80.5%–99.7%).
The alligator jaw forceps acquired subepithelial tissue in 32/40
biopsies (80%, 67.0%–92.9%), and the large-capacity forceps in
22/40 (55%, 38.9%–71.1%).
The use of static jaw and alligator forceps was associated with
higher success rates in obtaining subepithelial tissue compared
with the large-capacity forceps (●" Fig.3). There was no differ-
ence between the static jaw FB-11K-1 and static jaw FB-45Q-1
models for success in acquiring subepithelial tissue (P=0.265).
●" Fig.4 shows representative sections as sampled by the four dif-
ferent biopsy forceps models.
Amounts of epithelial and subepithelial tissue acquired
The surface areas of the epithelial and subepithelial tissue obtain-
ed using the four different biopsy forceps models are shown in
●" Table2. With regard to the amount of epithelial tissue sam-
pled, the large-capacity forceps provided the largest surface area
of epithelial tissue, followed by the alligator jaw, and the two sta-
tic jaw biopsy forceps (FB-11K-1 and FB-45Q-1). However, when
examining the amount of subepithelial tissue acquired, we found
that the static jaw FB-11K-1 forceps provided the largest tissue
surface area, followed by the static jaw FB-45Q-1, alligator, and
large-capacity forceps.
We further evaluated the ratio of surface area of epithelial tissue
to that of subepithelial tissue acquired (●" Table2). A ratio of 1
means that equal amounts of epithelial and subepithelial tissue
were acquired. The higher the ratio, the larger is the relative
amount of epithelial tissue acquired and the smaller the relative
amount of subepithelial tissue. We found that the static jaw FB-
45Q-1 had the lowest ratio (median 1.07), followed by the static
jaw FB-11K-1 (median 1.184), the alligator jaw (median 2.353),
and the large-capacity forceps (median 2.71).●" Table3 shows
the P values for the comparisons between the four different mod-
els of biopsy forceps, for surface area of acquired epithelial tissue,
for surface area of acquired subepithelial tissue, and for the epi-
thelial/subepithelial surface area ratios.
Static jaw 
FB-11K-1
116/120
Static jaw 
FB-45Q-1
37/40
P = 0.001
P < 0.001
P < 0.001
P = 0.265
P = 0.105
P = 0.017
Biopsies
Alligator jaw
32/40 
Large-capacity
22/40
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Fig.3 Success rate for sampling subepithelial tissue. Both static jaw for-
ceps models provided subepithelial tissue in >90% of biopsies. The alligator
jaw and large-capacity forceps provided subepithelial tissue in 80% and
55% of biopsies, respectively.
Fig.4 Representative examples (A–C) of sections
using the four different models of biopsy forceps.
The sections acquired with the large-capacity for-
ceps show a lack of basoapical orientation (observed
in 27.5% of biopsies sampled with this forceps type).
E, epithelial layer; SE, subepithelial layer.
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Orientation of the biopsy specimens
We further evaluated whether the presence of subepithelial tis-
sue acquired by the different biopsy forceps models might influ-
ence the chance of obtaining properly oriented biopsy specimens
(with epithelial side uppermost, sectioned perpendicularly to the
luminal surface).
●" Fig.4 shows examples of properly oriented samples, obtained
using the static jaw and the alligator jaw models, and badly
oriented biopsies obtained using the large-capacity model.
Rates for properly oriented esophageal biopsies were: static
jaw FB-11K-1 forceps, 112/120 (93.3%); static jaw FB-45K-1,
34/40 (85%); alligator jaw, 35/40 (87.5%); and large-capacity
forceps, 29/40 (72.5%).
When the static jaw FB-11K-1, static jaw FB-45K, and alligator
forceps were compared versus the large-capacity forceps, the P
valueswere <0.001, 0.172, and 0.094, respectively. No differences
regarding the rate of properly oriented biopsies were observed,
when the two static jaw and alligator forceps models were com-
pared with one another (static jaw FB-11K-1 vs. static jaw FB-
45Q-1, P=0.106; static jaw FB-11K-1 vs. alligator, P=0.242; alli-
gator jaw vs. static jaw FB-45Q-1, P=0.745).
Safety aspects
When biopsies were acquired using different biopsy models, we
observed no case of esophageal perforation or hemorrhage that
would necessitate an endoscopic or surgical hemostasis, or blood
transfusion, or hospitalization.
Discussion
!
In this first study comparing subepithelial tissue biopsy sampling
using four different forceps, we have identified the following
findings that are relevant to endoscopic and histologic work-up
of adult patients with EoE: (i) subepithelial tissue was acquired
in more than 90% of all biopsies using static jaw forceps, in 80%
of all biopsies using alligator jaw forceps, and in only 55% of biop-
sies using the large-capacity forceps; (ii) static jaw biopsy forceps
models had the lowest ratio of amount of epithelial to subepithe-
lial tissue sampled; (iii) the large-capacity forceps showed the
highest percentage (27.5%) of badly oriented esophageal biop-
sies; and (iv) deeper biopsy sampling using all biopsy forceps
models examined appears to be safe.
So far, most EoE-associated histologic alterations reported in the
literature are those observed in the epithelium and they are in-
flammatory in nature. These features include peak eosinophil
count, presence of eosinophilic microabscesses, eosinophil de-
granulation, papillary elongation, and basal cell hyperplasia of
the epithelium [21]. Evidence is increasing that the inflammatory
processes in EoE are not restricted to the epithelium but might
encompass all esophageal wall layers [4–8]. As yet, our knowl-
edge about pathogenic alterations in the subepithelial layer is
limited as this tissue is not routinely sampled. It would be advan-
tageous for several reasons to routinely acquire biopsies that en-
compass subepithelial tissue as well as epithelium.
First, sampling of subepithelial tissue can improve our under-
standing of EoE pathogenesis and clarify the relationship be-
Table 3 P values for comparisons, amongst four different biopsy forceps models, for surface area of epithelial tissue acquired, surface area of subepithelial
tissue acquired, and ratio of surface area of epithelial tissue to that of subepithelial tissue.
Static jaw
FB-11K-1
Static jaw
FB-45Q-1
Alligator jaw Large-capacity
Surface area of epithelial tissue Static jaw
FB-11K-1
–
0.003 0.922 < 0.001
Static jaw
FB-45Q-1
–
< 0.001 < 0.001
Alligator jaw – 0.007
Large-capacity –
Surface area of subepithelial tissue Static jaw
FB-11K-1
–
0.001 < 0.001 < 0.001
Static jaw
FB-45Q-1
–
0.037 < 0.001
Alligator jaw – 0.216
Large-capacity –
Ratio of surface areas, epithelial
tissue/ subepithelial tissue
Static jaw
FB-11K-1
–
0.560 0.144 0.004
Static jaw
FB-45Q-1
–
0.046 0.005
Alligator jaw – 0.253
Large-capacity –
Table 2 Characteristics of biopsies regarding the acquired area of epithelial and subepithelial layer, according to four forceps models.
Surface area, mean (SD), mm2 Ratio of surface areas epithelial layer/subepithelial layer,
median (IQR)
Epithelial tissue Subepithelial tissue
Static jaw FB-11K-1 0.949 (0.413) 0.857 (0.588) 1.184 (0.608 –2.454)
Static jaw FB-45Q-1 0.731 (0.344) 0.537 (0.332) 1.07 (0.65–2.327)
Alligator jaw 0.957 (0.414) 0.372 (0.367) 2.353 (1.312 –4.465)
Large-capacity 1.199 (0.425) 0.274 (0.381) 2.71 (1.611–4.858)
SD, standard deviation; IQR, interquartile range.
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tween symptom severity and biologic activity [13,22]. The pa-
thogenesis of EoE involves inflammatory as well as fibrotic pro-
cesses. Eosinophilic granulocytes in the subepithelial layer might
cause motility disturbances of the adjacent muscle layer [23]. In
the long term, untreated eosinophil-predominant inflammation
can lead to excessive subepithelial deposition of collagenous fi-
bers, mediated by transforming growth factor (TGF)-beta secre-
tion from mucosal eosinophils that stimulates fibroblasts to de-
posit extracellular matrix [9,10]. This ongoing remodeling pro-
cess can lead to reduction of esophageal caliber, stricture forma-
tion, and subsequent food bolus impactions [11,24]. In addition,
subepithelial fibrosis can lead tomotility disturbances and there-
by alter the esophageal clearance function and predispose to
acid-related disorders [25]. A total of 83.3% of our patients had
subepithelial fibrosis. This high proportion of patients with fibro-
sis is not surprising, bearing in mind a diagnostic delay of typical-
ly several years before diagnosis of EoE and that untreated in-
flammation leads to subepithelial fibrosis over time [11,26]. Fur-
thermore, our results are in accordance with findings from an
international EoE research group who documented subepithelial
fibrosis in >90% of their patients [19]. Fibrosis in EoE seems to be
at least partially reversible, in adult as well as pediatric patients,
by the long-term use of oral topical steroids but also of elimina-
tion diets [27–30]. As such, the histologic assessment of subepi-
thelial fibrosis allows clinicians to understand the severity of
esophageal remodeling.
A second advantage of sampling subepithelial tissue is that it can
help pathology technicians to correctly orient the biopsy speci-
mens before fixing them in formalin. The correct basoapical biop-
sy orientation (epithelial side up) provides sections that allow the
pathologist to assess all EoE-associated features [21]. As such,
correct orientation biopsy of the biopsy sample serves as a qual-
ity criterion in histopathology.
We found that both the static jaw forceps models (Olympus FB-
11K-1 and Olympus FB-45Q-1) allowed sampling of subepithelial
tissue in>90% of biopsies and were therefore superior to the alli-
gator jaw forceps and the large-capacity forceps. Furthermore,
the static jaw forceps models sampled a significantly larger area
of subepithelial tissue compared with the alligator jaw and the
large-capacity forcepsmodels. The highest rate of poorly oriented
biopsies (27.5%) was found for the large-capacity forceps which
was also the model that provided the lowest frequency of subepi-
thelial tissue. We conclude that static jaw forceps models are su-
perior to alligator or large-capacity forceps in sampling a larger
amount of subepithelial tissue.
Our study has several strengths and also some weaknesses. We
present the first study to systematically assess the performance
of four different biopsy forceps models in providing subepithelial
tissue. All the biopsies were performed by a single EoE expert fol-
lowing a standardized protocol. All the EoE samples were proces-
sed at a single expert pathology laboratory and all samples were
reviewed by a single EoE expert pathologist. As a first limitation,
it is important to point out that the goal of the study was to eval-
uate the performance of different biopsy forceps models in pro-
viding subepithelial tissue, and not to assess the clinical relevance
of sampling subepithelial tissue. As such, the clinical impact of
sampling subepithelial tissue in adult EoE patients still needs to
be evaluated. Second, our studymethodology relies on the obser-
vation that the frequency and severity of subepithelial fibrosis do
not differ between the proximal and distal esophagus in adult
EoE patients. No comments can currently be made regarding
fibrosis distribution in pediatric EoE patients. Third, the sample
size of 240 esophageal biopsies in 30 patients is too low to draw
definitive conclusions regarding the safety of subepithelial tissue
sampling. Finally, we did not perform an in-depth cost-effective-
ness analysis when comparing the single-use forceps versus mul-
ti-use forceps models. Considering that multi-use forceps models
(each costing about 400 euros) are typically used in 15–20 pa-
tients before being discarded, the costs per-patient are compar-
able to that of a single-use forceps (cost about 20 euros).
In conclusion, we compared biopsy sampling of subepithelial tis-
sue using four different forceps models, and found that use of a
static jaw forceps allows the endoscopist to sample subepithelial
tissue in more than 90% of all biopsies, and provides a greater
amount of subepithelial tissue, when compared with alligator
and large-capacity forceps. Obtaining biopsies using forceps
models that are more likely to sample subepithelial tissue ap-
pears to be safe. Obtaining deeper biopsies will increase our un-
derstanding of the pathogenesis of EoE. The clinical relevance of
assessing subepithelial tissue in adult EoE patients still needs to
be evaluated.
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